OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
It is important to understand regulatory requirements and study challenges at the clinical stage.
Automation of pharmaceutical packaging saves costs and time, say contract packagers.
When considering whether outsourcing to a CRO, one must consider the type of work, regulatory considerations, and study needs.
March 22, 2023
In addition to a new interim president, the company is opening new microbial capacity at its San Antonio facility and has plans to construct a commercial-scale facility in Manhattan, Kan.
March 08, 2023
Actylis new 30,000-ft² API manufacturing facility is located in Eugene, Ore.
March 07, 2023
In this episode, Rhonda Henry and Adam Mendizabal from Emmes discuss the role CROs play in cell and gene therapies undergoing clinical trials at all stages.
March 02, 2023
The trends shaping the growth of the biologics outsourcing industry demand attention.
The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.
February 22, 2023
Quotient Sciences’ facility expansion is designed to increase support for fully integrated drug development programs.
February 17, 2023
In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.
February 16, 2023
To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.
February 15, 2023
Shifting toward more technological solutions and ensuring a greater understanding of the workforce’s needs will give both CROs and sponsors a market advantage.
Growth in outsourcing has been the result of COVID-19 projects taking
precedence, which has pushed some contract manufacturing to second-tier CDMOs.